+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global High Potency Active Pharmaceutical Ingredients Market by Synthesis (Biotech API, Synthetic API), Application (Glaucoma, Hormonal Imbalance, Oncology) - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5637008
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The High Potency Active Pharmaceutical Ingredients Market size was estimated at USD 31.86 billion in 2023, USD 36.14 billion in 2024, and is expected to grow at a CAGR of 13.91% to reach USD 79.30 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the High Potency Active Pharmaceutical Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the High Potency Active Pharmaceutical Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the High Potency Active Pharmaceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca PLC, Asymchem Inc., Aurobindo Pharma Limited, BASF SE, BDR Pharmaceuticals Internationals Pvt. Ltd., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, CARBOGEN AMCIS AG, Eli Lilly and Company, Lonza Group AG, Merck & Co., Inc., Novartis AG, Sanofi S.A., and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the High Potency Active Pharmaceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Synthesis
    • Biotech API
    • Synthetic API
  • Application
    • Glaucoma
    • Hormonal Imbalance
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the High Potency Active Pharmaceutical Ingredients Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the High Potency Active Pharmaceutical Ingredients Market?
  3. What are the technology trends and regulatory frameworks in the High Potency Active Pharmaceutical Ingredients Market?
  4. What is the market share of the leading vendors in the High Potency Active Pharmaceutical Ingredients Market?
  5. Which modes and strategic moves are suitable for entering the High Potency Active Pharmaceutical Ingredients Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. High Potency Active Pharmaceutical Ingredients Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Ongoing expansion of pharmaceutical and CDMO industries across the globe
5.1.1.2. Significant investments in drug discovery and development
5.1.1.3. Rising requirement for targeted medicines by the oncology sector
5.1.2. Restraints
5.1.2.1. High costs associated with development of safe environment for manufacturing HPAPI
5.1.3. Opportunities
5.1.3.1. Favorable governmental approvals for new molecular entities
5.1.3.2. Ongoing research and development activities (R&D) for development of novel HPAPI
5.1.4. Challenges
5.1.4.1. Concerns associated with cytotoxic nature of high potency APIs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. High Potency Active Pharmaceutical Ingredients Market, by Synthesis
6.1. Introduction
6.2. Biotech API
6.3. Synthetic API
7. High Potency Active Pharmaceutical Ingredients Market, by Application
7.1. Introduction
7.2. Glaucoma
7.3. Hormonal Imbalance
7.4. Oncology
8. Americas High Potency Active Pharmaceutical Ingredients Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa High Potency Active Pharmaceutical Ingredients Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. AstraZeneca PLC
12.1.3. Asymchem Inc.
12.1.4. Aurobindo Pharma Limited
12.1.5. BASF SE
12.1.6. BDR Pharmaceuticals Internationals Pvt. Ltd.
12.1.7. Boehringer Ingelheim International GmbH
12.1.8. Bristol-Myers Squibb Company
12.1.9. CARBOGEN AMCIS AG
12.1.10. Eli Lilly and Company
12.1.11. Lonza Group AG
12.1.12. Merck & Co., Inc.
12.1.13. Novartis AG
12.1.14. Sanofi S.A.
12.1.15. Teva Pharmaceutical Industries Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
FIGURE 2. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
FIGURE 7. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2030 (%)
FIGURE 8. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 6. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 20. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 22. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 32. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 34. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 38. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 50. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 57. DENMARK HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EGYPT HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 59. EGYPT HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FINLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 61. FINLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 63. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 65. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 69. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NORWAY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 75. NORWAY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. POLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 77. POLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 79. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 87. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TURKEY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 93. TURKEY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 99. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 100. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • AstraZeneca PLC
  • Asymchem Inc.
  • Aurobindo Pharma Limited
  • BASF SE
  • BDR Pharmaceuticals Internationals Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • CARBOGEN AMCIS AG
  • Eli Lilly and Company
  • Lonza Group AG
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 36.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 79.3 Billion
Compound Annual Growth Rate13.9%
Regions CoveredGlobal

Related Topics

Related Reports

Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Forecast to 2029 - Product Image

Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Forecast to 2029

  • Report
  • 535 Pages
  • Global
From
High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
High Potency Active Pharmaceutical Ingredient Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

High Potency Active Pharmaceutical Ingredient Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 80 Pages
  • Global
From
Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Active Pharmaceutical Ingredients (API) - Global Strategic Business Report - Product Image

Active Pharmaceutical Ingredients (API) - Global Strategic Business Report

  • Report
  • 727 Pages
  • Global
From

About the High Potency API Market

The High Potency API (HPAI) market is a subset of the pharmaceutical intermediates market, focusing on the production of active pharmaceutical ingredients (APIs) with high potency. These APIs are used in the manufacture of drugs and other pharmaceutical products, and are typically produced in small quantities due to their potency. HPAI production requires specialized equipment and processes, as well as stringent safety protocols, to ensure the safety of workers and the environment. HPAI production is a complex process, involving multiple steps such as synthesis, purification, and formulation. The production of HPAI is highly regulated, and manufacturers must adhere to strict quality standards to ensure the safety and efficacy of their products. Companies in the HPAI market include Lonza, Boehringer Ingelheim, Dr. Reddy's Laboratories, and Aurobindo Pharma. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.